BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 33735224)

  • 1. Drug-resistant TB prevalence study in 5 health institutions in Haiti.
    Hoffmann J; Chedid C; Ocheretina O; Masetti C; Joseph P; Mabou MM; Mathon JE; Francois EM; Gebelin J; Babin FX; Raskine L; Pape JW
    PLoS One; 2021; 16(3):e0248707. PubMed ID: 33735224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
    Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
    PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.
    Zetola NM; Shin SS; Tumedi KA; Moeti K; Ncube R; Nicol M; Collman RG; Klausner JD; Modongo C
    J Clin Microbiol; 2014 Jul; 52(7):2422-9. PubMed ID: 24789181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
    PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology and drug sensitivity pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in and around Ambo Town, Central Ethiopia.
    Tilahun M; Ameni G; Desta K; Zewude A; Yamuah L; Abebe M; Aseffa A
    PLoS One; 2018; 13(2):e0193083. PubMed ID: 29447273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.
    Ocheretina O; Morose W; Gauthier M; Joseph P; D'Meza R; Escuyer VE; Rastogi N; Vernet G; Pape JW; Fitzgerald DW
    Rev Panam Salud Publica; 2012 Mar; 31(3):221-4. PubMed ID: 22569696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance and characterization of drug-resistant
    Imperiale BR; Di Giulio ÁB; Mancino MB; Zumárraga MJ; Morcillo NS
    Int J Mycobacteriol; 2019; 8(3):223-228. PubMed ID: 31512597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis-spoligo-rifampin-isoniazid typing: an all-in-one assay technique for surveillance and control of multidrug-resistant tuberculosis on Luminex devices.
    Gomgnimbou MK; Hernández-Neuta I; Panaiotov S; Bachiyska E; Palomino JC; Martin A; del Portillo P; Refregier G; Sola C
    J Clin Microbiol; 2013 Nov; 51(11):3527-34. PubMed ID: 23966495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
    Luo D; Chen Q; Xiong G; Peng Y; Liu T; Chen X; Zeng L; Chen K
    Sci Rep; 2019 May; 9(1):7315. PubMed ID: 31086215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors.
    Hang NT; Maeda S; Lien LT; Thuong PH; Hung NV; Thuy TB; Nanri A; Mizoue T; Hoang NP; Cuong VC; Ngoc KT; Sakurada S; Endo H; Keicho N
    PLoS One; 2013; 8(8):e71867. PubMed ID: 23967255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
    Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
    Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.